Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates

作者：Yan Li, Jian H. Song, Ruixin Ge, Xiangrui Luo, Ping Zhou, Ping Zhou, Hanyue Lei, Rouhan Qian, Fan Zhang, Wei Pan, Miao Chen, Jingrui Li, Xifeng Dong, Tianliang Li, Sijin Wu, Jun Zhou, Songbo Xie · 发表于：European Journal of Medicinal Chemistry · 年份：2025 · DOI：10.1016/j.ejmech.2025.117871 · 被引用次数：6 · 研究领域：Lung Cancer Treatments and Mutations、HER2/EGFR in Cancer Research、Cancer therapeutics and mechanisms